$206.63
-1.82-0.87%
At close: Aug 5, 5:00 PM EST
$206.63
N/A
After Hours: 4:00 PM EST
Biogen Inc Earnings Estimates
BIIBNASDAQ
Biogen Earnings Estimates, EPS & Revenue | NASDAQ:BIIB
Biogen (BIIB) is scheduled to report Q3 earnings on October 29, 2026. Analysts estimate EPS of $3.93 and quarterly revenue of $2.57B.
In the most recent quarter (Q2), Biogen reported EPS of $3.60, beating estimates of $2.35 by 0.53%. Revenue came in at $2.74B, exceeding the estimate of $2.42B by 0.13%.
Biogen has beaten EPS estimates in 8 consecutive quarters.
Over the last 4 quarters, Biogen has averaged an EPS surprise of 0.30% and a revenue surprise of 0.09%.
Earnings Date
Oct 29
EPS Estimate
$3.930
Quarterly Revenue Estimate
$2.57B
Annual Revenue
$10.03B
as of Jun 30
Biogen Earnings History
Analyze the earnings history of Biogen using advanced sorting and filters.
Biogen (BIIB) Earnings Per Share
The chart below shows Biogen's reported EPS compared to analyst estimates over recent quarters.
Biogen (BIIB) Revenue
The chart below shows Biogen's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen (BIIB) is scheduled to report earnings on October 29, 2026. The last reported earnings were for reported on July 29, 2026 for Q2.
What were the latest earnings per share (EPS) for Biogen (NASDAQ:BIIB)?
The Actual EPS was $3.60, which beat the estimate of $2.35.
What were Biogen’s (NASDAQ:BIIB) revenues?
The Actual Revenue was $2.74B, which beat the estimate of $2.42B.
